HEADER HORMONE 20-FEB-12 4AJX TITLE LIGAND CONTROLLED ASSEMBLY OF HEXAMERS, DIHEXAMERS, AND LINEAR TITLE 2 MULTIHEXAMER STRUCTURES BY AN ENGINEERED ACYLATED INSULIN COMPND MOL_ID: 1; COMPND 2 MOLECULE: INSULIN; COMPND 3 CHAIN: A, C, E, G, I, K; COMPND 4 ENGINEERED: YES; COMPND 5 MOL_ID: 2; COMPND 6 MOLECULE: INSULIN; COMPND 7 CHAIN: B, D, F, H, J, L; COMPND 8 FRAGMENT: RESIDUES 25-53; COMPND 9 ENGINEERED: YES; COMPND 10 OTHER_DETAILS: DELTA 30, SYNTHETICALLY MODIFIED AT LYS 29 SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: SACCHAROMYCES CEREVISIAE; SOURCE 6 EXPRESSION_SYSTEM_COMMON: BAKER'S YEAST; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 4932; SOURCE 8 MOL_ID: 2; SOURCE 9 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 10 ORGANISM_COMMON: HUMAN; SOURCE 11 ORGANISM_TAXID: 9606; SOURCE 12 EXPRESSION_SYSTEM: SACCHAROMYCES CEREVISIAE; SOURCE 13 EXPRESSION_SYSTEM_COMMON: BAKER'S YEAST; SOURCE 14 EXPRESSION_SYSTEM_TAXID: 4932 KEYWDS HORMONE EXPDTA X-RAY DIFFRACTION AUTHOR D.B.STEENSGAARD,G.SCHLUCKEBIER,H.M.STRAUSS,M.NORRMAN,J.K.THOMSEN, AUTHOR 2 A.V.FRIDERICHSEN,S.HAVELUND,I.JONASSEN REVDAT 4 20-DEC-23 4AJX 1 REMARK LINK REVDAT 3 24-JUN-15 4AJX 1 REMARK REVDAT 2 30-JAN-13 4AJX 1 JRNL REVDAT 1 09-JAN-13 4AJX 0 JRNL AUTH D.B.STEENSGAARD,G.SCHLUCKEBIER,H.M.STRAUSS,M.NORRMAN, JRNL AUTH 2 J.K.THOMSEN,A.V.FRIDERICHSEN,S.HAVELUND,I.JONASSEN JRNL TITL LIGAND CONTROLLED ASSEMBLY OF HEXAMERS, DIHEXAMERS, AND JRNL TITL 2 LINEAR MULTIHEXAMER STRUCTURES BY THE ENGINEERED ACYLATED JRNL TITL 3 INSULIN DEGLUDEC. JRNL REF BIOCHEMISTRY V. 52 295 2013 JRNL REFN ISSN 0006-2960 JRNL PMID 23256685 JRNL DOI 10.1021/BI3008609 REMARK 2 REMARK 2 RESOLUTION. 1.20 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX (PHENIX.REFINE: DEV_947) REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.20 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 40.50 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.990 REMARK 3 COMPLETENESS FOR RANGE (%) : 92.7 REMARK 3 NUMBER OF REFLECTIONS : 89598 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.142 REMARK 3 R VALUE (WORKING SET) : 0.141 REMARK 3 FREE R VALUE : 0.160 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 4449 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 40.5202 - 3.7278 0.99 3111 185 0.1716 0.1675 REMARK 3 2 3.7278 - 2.9591 1.00 3054 180 0.1525 0.1514 REMARK 3 3 2.9591 - 2.5851 1.00 3093 159 0.1516 0.1663 REMARK 3 4 2.5851 - 2.3488 1.00 3105 142 0.1369 0.1593 REMARK 3 5 2.3488 - 2.1805 0.91 2779 147 0.1295 0.1514 REMARK 3 6 2.1805 - 2.0519 0.95 2894 161 0.1252 0.1456 REMARK 3 7 2.0519 - 1.9492 0.99 3042 179 0.1237 0.1524 REMARK 3 8 1.9492 - 1.8643 0.85 2602 142 0.1379 0.1533 REMARK 3 9 1.8643 - 1.7925 1.00 3076 154 0.1160 0.1515 REMARK 3 10 1.7925 - 1.7307 1.00 3039 164 0.1076 0.1411 REMARK 3 11 1.7307 - 1.6766 1.00 3067 156 0.1006 0.1219 REMARK 3 12 1.6766 - 1.6286 1.00 3041 163 0.0981 0.1234 REMARK 3 13 1.6286 - 1.5858 1.00 3067 161 0.0935 0.1313 REMARK 3 14 1.5858 - 1.5471 1.00 3039 163 0.0956 0.1335 REMARK 3 15 1.5471 - 1.5119 0.96 2906 146 0.1061 0.1375 REMARK 3 16 1.5119 - 1.4797 1.00 3046 161 0.1005 0.1356 REMARK 3 17 1.4797 - 1.4501 0.98 3017 146 0.1244 0.1762 REMARK 3 18 1.4501 - 1.4228 0.99 3009 184 0.1207 0.1596 REMARK 3 19 1.4228 - 1.3974 1.00 3042 151 0.1093 0.1340 REMARK 3 20 1.3974 - 1.3737 0.99 2999 176 0.1177 0.1631 REMARK 3 21 1.3737 - 1.3515 0.96 2930 125 0.1311 0.1689 REMARK 3 22 1.3515 - 1.3307 1.00 3083 143 0.1190 0.1563 REMARK 3 23 1.3307 - 1.3111 1.00 3072 141 0.1312 0.1772 REMARK 3 24 1.3111 - 1.2927 0.94 2903 155 0.2260 0.2889 REMARK 3 25 1.2927 - 1.2752 0.88 2655 127 0.1944 0.2182 REMARK 3 26 1.2752 - 1.2586 0.79 2433 121 0.2397 0.3067 REMARK 3 27 1.2586 - 1.2429 0.75 2276 119 0.2103 0.2221 REMARK 3 28 1.2429 - 1.2279 0.68 2077 117 0.2184 0.2163 REMARK 3 29 1.2279 - 1.2136 0.62 1900 96 0.2926 0.3409 REMARK 3 30 1.2136 - 1.2000 0.58 1792 85 0.2056 0.1955 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 0.90 REMARK 3 SHRINKAGE RADIUS : 0.60 REMARK 3 K_SOL : 0.40 REMARK 3 B_SOL : 59.62 REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.100 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 15.140 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 11.72 REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.41820 REMARK 3 B22 (A**2) : -0.36650 REMARK 3 B33 (A**2) : 0.78470 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : -0.01880 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.014 2672 REMARK 3 ANGLE : 1.614 3625 REMARK 3 CHIRALITY : 0.098 397 REMARK 3 PLANARITY : 0.008 469 REMARK 3 DIHEDRAL : 15.189 963 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 4AJX COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 20-FEB-12. REMARK 100 THE DEPOSITION ID IS D_1290051382. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 15-MAR-05 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SLS REMARK 200 BEAMLINE : X06SA REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0000 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XSCALE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 90966 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.200 REMARK 200 RESOLUTION RANGE LOW (A) : 40.500 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 92.4 REMARK 200 DATA REDUNDANCY : 4.200 REMARK 200 R MERGE (I) : 0.03600 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 19.1500 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.20 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.23 REMARK 200 COMPLETENESS FOR SHELL (%) : 60.3 REMARK 200 DATA REDUNDANCY IN SHELL : 2.70 REMARK 200 R MERGE FOR SHELL (I) : 0.41000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.510 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: PDB ENTRY 1EVR REMARK 200 REMARK 200 REMARK: NONE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 46.33 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.29 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.6 M IMIDAZOLE/MALONIC ACID PH 7.0 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 31.24500 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DODECAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 5690 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 11370 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -94.4 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C, D, E, F, G, H, I, J, REMARK 350 AND CHAINS: K, L REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 LYS D 29 REMARK 465 LYS F 29 REMARK 465 LYS J 29 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 PHE F 25 CG CD1 CD2 CE1 CE2 CZ REMARK 470 PHE H 1 CG CD1 CD2 CE1 CE2 CZ REMARK 470 ARG H 22 CG CD NE CZ NH1 NH2 REMARK 470 ARG J 22 CG CD NE CZ NH1 NH2 REMARK 470 PHE L 1 CG CD1 CD2 CE1 CE2 CZ REMARK 470 ASN L 3 CG OD1 ND2 REMARK 480 REMARK 480 ZERO OCCUPANCY ATOM REMARK 480 THE FOLLOWING RESIDUES HAVE ATOMS MODELED WITH ZERO REMARK 480 OCCUPANCY. THE LOCATION AND PROPERTIES OF THESE ATOMS REMARK 480 MAY NOT BE RELIABLE. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 480 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 480 M RES C SSEQI ATOMS REMARK 480 LYS H 29 O CB CG CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O GLU E 4 HG1 THR E 8 1.54 REMARK 500 HE21 GLN H 4 O08 16E H 1031 1.55 REMARK 500 O HOH B 2025 O HOH B 2028 1.85 REMARK 500 O HOH A 2017 O HOH A 2031 1.91 REMARK 500 O HOH A 2025 O HOH A 2032 1.93 REMARK 500 O HOH F 2017 O HOH F 2019 1.96 REMARK 500 O HOH K 2007 O HOH K 2009 2.03 REMARK 500 O HOH D 2017 O HOH D 2021 2.05 REMARK 500 O GLU E 4 OG1 THR E 8 2.07 REMARK 500 O HOH B 2028 O HOH H 2019 2.08 REMARK 500 O HOH G 2015 O HOH G 2017 2.11 REMARK 500 O HOH B 2028 O HOH B 2029 2.11 REMARK 500 O HOH A 2007 O HOH A 2008 2.11 REMARK 500 O HOH A 2024 O HOH A 2026 2.12 REMARK 500 O HOH A 2017 O HOH A 2018 2.12 REMARK 500 O HOH C 2010 O HOH C 2032 2.15 REMARK 500 O HOH C 2022 O HOH F 2017 2.17 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 O HOH A 2023 O HOH C 2012 1655 1.99 REMARK 500 CD ARG D 22 O HOH A 2051 1455 2.00 REMARK 500 NE ARG D 22 O08 16E A 1022 1455 2.05 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 VAL L 12 CB VAL L 12 CG2 -0.129 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 LEU B 17 CB - CG - CD1 ANGL. DEV. = 17.6 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 CYS D 19 53.90 -106.94 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A2022 DISTANCE = 6.69 ANGSTROMS REMARK 615 REMARK 615 ZERO OCCUPANCY ATOM REMARK 615 THE FOLLOWING RESIDUES HAVE ATOMS MODELED WITH ZERO REMARK 615 OCCUPANCY. THE LOCATION AND PROPERTIES OF THESE ATOMS REMARK 615 MAY NOT BE RELIABLE. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 615 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 615 M RES C SSEQI REMARK 615 16E H 1031 REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 NA B1031 NA REMARK 620 N RES CSSEQI ATOM REMARK 620 1 16E A1022 O08 REMARK 620 2 HOH A2004 O 115.0 REMARK 620 3 HOH A2013 O 109.9 76.1 REMARK 620 4 HOH B2037 O 138.8 95.3 103.9 REMARK 620 N 1 2 3 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 NA H1032 NA REMARK 620 N RES CSSEQI ATOM REMARK 620 1 SER B 9 OG REMARK 620 2 HOH B2016 O 47.8 REMARK 620 3 GLU H 13 OE1 86.6 109.7 REMARK 620 4 GLU H 13 O 142.6 148.4 101.4 REMARK 620 5 GLU L 13 OE2 119.7 74.7 99.2 95.3 REMARK 620 N 1 2 3 4 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 ZN F1029 ZN REMARK 620 N RES CSSEQI ATOM REMARK 620 1 HIS B 10 NE2 REMARK 620 2 HIS F 10 NE2 110.9 REMARK 620 3 HIS L 10 NE2 110.7 109.4 REMARK 620 4 IMD L1031 N1 113.7 101.5 110.3 REMARK 620 N 1 2 3 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 ZN H1030 ZN REMARK 620 N RES CSSEQI ATOM REMARK 620 1 HIS D 10 NE2 REMARK 620 2 HIS H 10 NE2 105.4 REMARK 620 3 16E H1031 O28 115.5 120.9 REMARK 620 4 HIS J 10 NE2 106.4 106.2 101.3 REMARK 620 N 1 2 3 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 16E A 1022 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE RCO B 1030 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE NA B 1031 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE RCO D 1029 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE IMD D 1030 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE RCO E 1022 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ZN F 1029 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC8 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE RCO G 1022 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC9 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ZN H 1030 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 16E H 1031 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE NA H 1032 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE RCO J 1029 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE IMD K 1022 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE RCO L 1030 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE IMD L 1031 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1A7F RELATED DB: PDB REMARK 900 INSULIN MUTANT B16 GLU, B24 GLY, DES-B30, NMR, 20 STRUCTURES REMARK 900 RELATED ID: 1AI0 RELATED DB: PDB REMARK 900 R6 HUMAN INSULIN HEXAMER (NON-SYMMETRIC), NMR, 10 STRUCTURES REMARK 900 RELATED ID: 1AIY RELATED DB: PDB REMARK 900 R6 HUMAN INSULIN HEXAMER (SYMMETRIC), NMR, 10 STRUCTURES REMARK 900 RELATED ID: 1B9E RELATED DB: PDB REMARK 900 HUMAN INSULIN MUTANT SERB9GLU REMARK 900 RELATED ID: 1BEN RELATED DB: PDB REMARK 900 INSULIN COMPLEXED WITH 4-HYDROXYBENZAMIDE REMARK 900 RELATED ID: 1EFE RELATED DB: PDB REMARK 900 AN ACTIVE MINI-PROINSULIN, M2PI REMARK 900 RELATED ID: 1EV3 RELATED DB: PDB REMARK 900 STRUCTURE OF THE RHOMBOHEDRAL FORM OF THE M-CRESOL/ INSULIN R6 REMARK 900 HEXAMER REMARK 900 RELATED ID: 1EV6 RELATED DB: PDB REMARK 900 STRUCTURE OF THE MONOCLINIC FORM OF THE M-CRESOL/ INSULIN R6 HEXAMER REMARK 900 RELATED ID: 1EVR RELATED DB: PDB REMARK 900 THE STRUCTURE OF THE RESORCINOL/INSULIN R6 HEXAMER REMARK 900 RELATED ID: 1FU2 RELATED DB: PDB REMARK 900 FIRST PROTEIN STRUCTURE DETERMINED FROM X-RAY POWDERDIFFRACTION DATA REMARK 900 RELATED ID: 1FUB RELATED DB: PDB REMARK 900 FIRST PROTEIN STRUCTURE DETERMINED FROM X-RAY POWDERDIFFRACTION DATA REMARK 900 RELATED ID: 1G7A RELATED DB: PDB REMARK 900 1.2 A STRUCTURE OF T3R3 HUMAN INSULIN AT 100 K REMARK 900 RELATED ID: 1G7B RELATED DB: PDB REMARK 900 1.3 A STRUCTURE OF T3R3 HUMAN INSULIN AT 100 K REMARK 900 RELATED ID: 1GUJ RELATED DB: PDB REMARK 900 INSULIN AT PH 2: STRUCTURAL ANALYSIS OF THE CONDITIONS PROMOTING REMARK 900 INSULIN FIBRE FORMATION. REMARK 900 RELATED ID: 1HIQ RELATED DB: PDB REMARK 900 INSULIN (HUMAN) MUTANT WITH PHE B 24 REPLACED BY SER (F24S) (NMR, REMARK 900 REPRESENTATIVE PLUS 9 STRUCTURES) REMARK 900 RELATED ID: 1HIS RELATED DB: PDB REMARK 900 INSULIN (HUMAN, DES-PENTAPEPTIDE (B 26 - B 30)) (NMR , REMARK 900 REPRESENTATIVE PLUS 14 STRUCTURES) REMARK 900 RELATED ID: 1HIT RELATED DB: PDB REMARK 900 INSULIN (HUMAN) MUTANT WITH PHE B 24 REPLACED BY GLY (F24G) (NMR, REMARK 900 REPRESENTATIVE PLUS 8 STRUCTURES) REMARK 900 RELATED ID: 1HLS RELATED DB: PDB REMARK 900 NMR STRUCTURE OF THE HUMAN INSULIN-HIS(B16) REMARK 900 RELATED ID: 1HTV RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF DESTRIPEPTIDE (B28-B30) INSULIN REMARK 900 RELATED ID: 1HUI RELATED DB: PDB REMARK 900 INSULIN MUTANT (B1, B10, B16, B27)GLU, DES-B30, NMR , 25 STRUCTURES REMARK 900 RELATED ID: 1IOG RELATED DB: PDB REMARK 900 INSULIN MUTANT A3 GLY,(B1, B10, B16, B27)GLU, DES- B30, NMR, 19 REMARK 900 STRUCTURES REMARK 900 RELATED ID: 1IOH RELATED DB: PDB REMARK 900 INSULIN MUTANT A8 HIS,(B1, B10, B16, B27)GLU, DES- B30, NMR, 26 REMARK 900 STRUCTURES REMARK 900 RELATED ID: 1J73 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF AN UNSTABLE INSULIN ANALOG WITH NATIVEACTIVITY. REMARK 900 RELATED ID: 1JCA RELATED DB: PDB REMARK 900 NON-STANDARD DESIGN OF UNSTABLE INSULIN ANALOGUES WITHENHANCED REMARK 900 ACTIVITY REMARK 900 RELATED ID: 1JCO RELATED DB: PDB REMARK 900 SOLUTION STRUCTURE OF THE MONOMERIC [THR(B27)->PRO,PRO (B28)->THR] REMARK 900 INSULIN MUTANT (PT INSULIN) REMARK 900 RELATED ID: 1K3M RELATED DB: PDB REMARK 900 NMR STRUCTURE OF HUMAN INSULIN MUTANT ILE-A2-ALA, HIS-B10-ASP, PRO- REMARK 900 B28-LYS, LYS-B29-PRO, 15 STRUCTURES REMARK 900 RELATED ID: 1KMF RELATED DB: PDB REMARK 900 NMR STRUCTURE OF HUMAN INSULIN MUTANT ILE-A2-ALLO- ILE, HIS-B10-ASP, REMARK 900 PRO-B28-LYS, LYS-B29-PRO, 15 STRUCTURES REMARK 900 RELATED ID: 1LKQ RELATED DB: PDB REMARK 900 NMR STRUCTURE OF HUMAN INSULIN MUTANT ILE-A2-GLY, VAL-A3-GLY, HIS- REMARK 900 B10-ASP, PRO-B28-LYS, LYS-B29- PRO, 20 STRUCTURES REMARK 900 RELATED ID: 1LPH RELATED DB: PDB REMARK 900 LYS(B28)PRO(B29)-HUMAN INSULIN REMARK 900 RELATED ID: 1MHI RELATED DB: PDB REMARK 900 RELATED ID: 1MHJ RELATED DB: PDB REMARK 900 RELATED ID: 1MSO RELATED DB: PDB REMARK 900 T6 HUMAN INSULIN AT 1.0 A RESOLUTION REMARK 900 RELATED ID: 1OS3 RELATED DB: PDB REMARK 900 DEHYDRATED T6 HUMAN INSULIN AT 100 K REMARK 900 RELATED ID: 1OS4 RELATED DB: PDB REMARK 900 DEHYDRATED T6 HUMAN INSULIN AT 295 K REMARK 900 RELATED ID: 1Q4V RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF ALLO-ILEA2-INSULIN, AN INACTIVE CHIRALANALOGUE: REMARK 900 IMPLICATIONS FOR THE MECHANISM OF RECEPTOR REMARK 900 RELATED ID: 1QIY RELATED DB: PDB REMARK 900 HUMAN INSULIN HEXAMERS WITH CHAIN B HIS MUTATED TO TYR COMPLEXED REMARK 900 WITH PHENOL REMARK 900 RELATED ID: 1QIZ RELATED DB: PDB REMARK 900 HUMAN INSULIN HEXAMERS WITH CHAIN B HIS MUTATED TO TYR COMPLEXED REMARK 900 WITH RESORCINOL REMARK 900 RELATED ID: 1QJ0 RELATED DB: PDB REMARK 900 HUMAN INSULIN HEXAMERS WITH CHAIN B HIS MUTATED TO TYR REMARK 900 RELATED ID: 1RWE RELATED DB: PDB REMARK 900 ENHANCING THE ACTIVITY OF INSULIN AT RECEPTOR EDGE: REMARK 900 CRYSTALSTRUCTURE AND PHOTO-CROSS-LINKING OF A8 ANALOGUES REMARK 900 RELATED ID: 1SF1 RELATED DB: PDB REMARK 900 NMR STRUCTURE OF HUMAN INSULIN UNDER AMYLOIDOGENICCONDITION, 15 REMARK 900 STRUCTURES REMARK 900 RELATED ID: 1SJT RELATED DB: PDB REMARK 900 MINI-PROINSULIN, TWO CHAIN INSULIN ANALOG MUTANT: DES B30, HIS(B 10) REMARK 900 ASP, PRO(B 28)ASP, NMR, 20 STRUCTURES REMARK 900 RELATED ID: 1T0C RELATED DB: PDB REMARK 900 SOLUTION STRUCTURE OF HUMAN PROINSULIN C-PEPTIDE REMARK 900 RELATED ID: 1T1K RELATED DB: PDB REMARK 900 NMR STRUCTURE OF HUMAN INSULIN MUTANT HIS-B10-ASP, VAL-B12-ALA, PRO- REMARK 900 B28-LYS, LYS-B29-PRO, 15 STRUCTURES REMARK 900 RELATED ID: 1T1P RELATED DB: PDB REMARK 900 NMR STRUCTURE OF HUMAN INSULIN MUTANT HIS-B10-ASP, VAL-B12-THR, PRO- REMARK 900 B28-LYS, LYS-B29-PRO, 15 STRUCTURES REMARK 900 RELATED ID: 1T1Q RELATED DB: PDB REMARK 900 NMR STRUCTURE OF HUMAN INSULIN MUTANT HIS-B10-ASP, VAL-B12-ABA, PRO- REMARK 900 B28-LYS, LYS-B29-PRO, 15 STRUCTURES REMARK 900 RELATED ID: 1TRZ RELATED DB: PDB REMARK 900 INSULIN (T3R3) COMPLEX WITH TWO ZINC IONS REMARK 900 RELATED ID: 1TYL RELATED DB: PDB REMARK 900 INSULIN (T3R3) (PH 6.4, 0.75 M NACL) COMPLEXED WITH TWO ZINC IONS REMARK 900 AND TYLENOL (4'-HYDROXYACETANILIDE) REMARK 900 RELATED ID: 1TYM RELATED DB: PDB REMARK 900 INSULIN (T3R3) (PH 5.6, 1.0 M NACL) COMPLEXED WITH TWO ZINC IONS REMARK 900 AND TYLENOL (4'-HYDROXYACETANILIDE) REMARK 900 RELATED ID: 1UZ9 RELATED DB: PDB REMARK 900 CRYSTALLOGRAPHIC AND SOLUTION STUDIES OF N-LITHOCHOLYL INSULIN: A REMARK 900 NEW GENERATION OF PROLONGED-ACTING INSULINS. REMARK 900 RELATED ID: 1VKT RELATED DB: PDB REMARK 900 HUMAN INSULIN TWO DISULFIDE MODEL, NMR, 10 STRUCTURES REMARK 900 RELATED ID: 1W8P RELATED DB: PDB REMARK 900 STRUCTURAL PROPERTIES OF THE B25TYR-NME-B26PHE INSULIN MUTANT. REMARK 900 RELATED ID: 1XDA RELATED DB: PDB REMARK 900 STRUCTURE OF INSULIN REMARK 900 RELATED ID: 1XGL RELATED DB: PDB REMARK 900 HUMAN INSULIN DISULFIDE ISOMER, NMR, 10 STRUCTURES REMARK 900 RELATED ID: 1XW7 RELATED DB: PDB REMARK 900 DIABETES-ASSOCIATED MUTATIONS IN HUMAN INSULIN: CRYSTALSTRUCTURE REMARK 900 AND PHOTO-CROSS-LINKING STUDIES OF A- CHAINVARIANT INSULIN WAKAYAMA REMARK 900 RELATED ID: 1ZEG RELATED DB: PDB REMARK 900 STRUCTURE OF B28 ASP INSULIN IN COMPLEX WITH PHENOL REMARK 900 RELATED ID: 1ZEH RELATED DB: PDB REMARK 900 STRUCTURE OF INSULIN REMARK 900 RELATED ID: 1ZNJ RELATED DB: PDB REMARK 900 INSULIN, MONOCLINIC CRYSTAL FORM REMARK 900 RELATED ID: 2AIY RELATED DB: PDB REMARK 900 R6 HUMAN INSULIN HEXAMER (SYMMETRIC), NMR, 20 STRUCTURES REMARK 900 RELATED ID: 2C8Q RELATED DB: PDB REMARK 900 INSULINE(1SEC) AND UV LASER EXCITED FLUORESCENCE REMARK 900 RELATED ID: 2C8R RELATED DB: PDB REMARK 900 INSULINE(60SEC) AND UV LASER EXCITED FLUORESCENCE REMARK 900 RELATED ID: 2CEU RELATED DB: PDB REMARK 900 DESPENTAPEPTIDE INSULIN IN ACETIC ACID (PH 2) REMARK 900 RELATED ID: 2H67 RELATED DB: PDB REMARK 900 NMR STRUCTURE OF HUMAN INSULIN MUTANT HIS-B5-ALA, HIS-B10-ASP PRO- REMARK 900 B28-LYS, LYS-B29-PRO, 20 STRUCTURES REMARK 900 RELATED ID: 2HH4 RELATED DB: PDB REMARK 900 NMR STRUCTURE OF HUMAN INSULIN MUTANT GLY-B8-D-SER , HIS-B10-ASP REMARK 900 PRO-B28-LYS, LYS-B29-PRO, 20 STRUCTURES REMARK 900 RELATED ID: 2HHO RELATED DB: PDB REMARK 900 NMR STRUCTURE OF HUMAN INSULIN MUTANT GLY-B8-SER, HIS-B10-ASP PRO- REMARK 900 B28-LYS, LYS-B29-PRO, 20 STRUCTURES REMARK 900 RELATED ID: 2HIU RELATED DB: PDB REMARK 900 NMR STRUCTURE OF HUMAN INSULIN IN 20% ACETIC ACID, ZINC-FREE, 10 REMARK 900 STRUCTURES REMARK 900 RELATED ID: 2VJZ RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE FORM ULTALENTE INSULIN MICROCRYSTALS REMARK 900 RELATED ID: 2VK0 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE FORM ULTALENTE INSULIN MICROCRYSTALS REMARK 900 RELATED ID: 2W44 RELATED DB: PDB REMARK 900 STRUCTURE DELTAA1-A4 INSULIN REMARK 900 RELATED ID: 2WBY RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN INSULIN-DEGRADING ENZYME IN COMPLEX WITH REMARK 900 INSULIN REMARK 900 RELATED ID: 2WC0 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN INSULIN DEGRADING ENZYME IN COMPLEX WITH REMARK 900 IODINATED INSULIN REMARK 900 RELATED ID: 2WRU RELATED DB: PDB REMARK 900 SEMI-SYNTHETIC HIGHLY ACTIVE ANALOGUE OF HUMAN INSULIN NMEALAB26- REMARK 900 DTI-NH2 REMARK 900 RELATED ID: 2WRV RELATED DB: PDB REMARK 900 SEMI-SYNTHETIC HIGHLY ACTIVE ANALOGUE OF HUMAN INSULIN NMEHISB26- REMARK 900 DTI-NH2 REMARK 900 RELATED ID: 2WRW RELATED DB: PDB REMARK 900 SEMI-SYNTHETIC HIGHLY ACTIVE ANALOGUE OF HUMAN INSULIN D-PROB26-DTI- REMARK 900 NH2 REMARK 900 RELATED ID: 2WRX RELATED DB: PDB REMARK 900 SEMI-SYNTHETIC ANALOGUE OF HUMAN INSULIN NMEALAB26- INSULIN AT PH REMARK 900 3.0 REMARK 900 RELATED ID: 2WS0 RELATED DB: PDB REMARK 900 SEMI-SYNTHETIC ANALOGUE OF HUMAN INSULIN NMEALAB26- INSULIN AT PH REMARK 900 7.5 REMARK 900 RELATED ID: 2WS1 RELATED DB: PDB REMARK 900 SEMI-SYNTHETIC ANALOGUE OF HUMAN INSULIN NMETYRB26- INSULIN IN REMARK 900 MONOMER FORM REMARK 900 RELATED ID: 2WS4 RELATED DB: PDB REMARK 900 SEMI-SYNTHETIC ANALOGUE OF HUMAN INSULIN PROB26-DTI IN MONOMER FORM REMARK 900 RELATED ID: 2WS6 RELATED DB: PDB REMARK 900 SEMI-SYNTHETIC ANALOGUE OF HUMAN INSULIN NMETYRB26- INSULIN IN REMARK 900 HEXAMER FORM REMARK 900 RELATED ID: 2WS7 RELATED DB: PDB REMARK 900 SEMI-SYNTHETIC ANALOGUE OF HUMAN INSULIN PROB26-DTI REMARK 900 RELATED ID: 3AIY RELATED DB: PDB REMARK 900 R6 HUMAN INSULIN HEXAMER (SYMMETRIC), NMR, REFINED AVERAGE STRUCTURE REMARK 900 RELATED ID: 3ZQR RELATED DB: PDB REMARK 900 NMEPHEB25 INSULIN ANALOGUE CRYSTAL STRUCTURE REMARK 900 RELATED ID: 3ZS2 RELATED DB: PDB REMARK 900 TYRB25,NMEPHEB26,LYSB28,PROB29-INSULIN ANALOGUE CRYSTAL STRUCTURE REMARK 900 RELATED ID: 3ZU1 RELATED DB: PDB REMARK 900 STRUCTURE OF LYSB29(NEPSILON OMEGA-CARBOXYHEPTADECANOYL) DES(B30) REMARK 900 HUMAN INSULIN REMARK 900 RELATED ID: 4AIY RELATED DB: PDB REMARK 900 R6 HUMAN INSULIN HEXAMER (SYMMETRIC), NMR, 'GREEN' SUBSTATE, REMARK 900 AVERAGE STRUCTURE REMARK 900 RELATED ID: 4AJZ RELATED DB: PDB REMARK 900 LIGAND CONTROLLED ASSEMBLY OF HEXAMERS, DIHEXAMERS, AND LINEAR REMARK 900 MULTIHEXAMER STRUCTURES BY AN ENGINEERED ACYLATED INSULIN REMARK 900 RELATED ID: 4AK0 RELATED DB: PDB REMARK 900 LIGAND CONTROLLED ASSEMBLY OF HEXAMERS, DIHEXAMERS, AND LINEAR REMARK 900 MULTIHEXAMER STRUCTURES BY AN ENGINEERED ACYLATED INSULIN REMARK 900 RELATED ID: 4AKJ RELATED DB: PDB REMARK 900 LIGAND CONTROLLED ASSEMBLY OF HEXAMERS, DIHEXAMERS, AND LINEAR REMARK 900 MULTIHEXAMER STRUCTURES BY AN ENGINEERED ACYLATED INSULIN REMARK 900 RELATED ID: 5AIY RELATED DB: PDB REMARK 900 R6 HUMAN INSULIN HEXAMER (SYMMETRIC), NMR, 'RED' SUBSTATE, AVERAGE REMARK 900 STRUCTURE DBREF 4AJX A 1 21 UNP P01308 INS_HUMAN 90 110 DBREF 4AJX B 1 29 UNP P01308 INS_HUMAN 25 53 DBREF 4AJX C 1 21 UNP P01308 INS_HUMAN 90 110 DBREF 4AJX D 1 29 UNP P01308 INS_HUMAN 25 53 DBREF 4AJX E 1 21 UNP P01308 INS_HUMAN 90 110 DBREF 4AJX F 1 29 UNP P01308 INS_HUMAN 25 53 DBREF 4AJX G 1 21 UNP P01308 INS_HUMAN 90 110 DBREF 4AJX H 1 29 UNP P01308 INS_HUMAN 25 53 DBREF 4AJX I 1 21 UNP P01308 INS_HUMAN 90 110 DBREF 4AJX J 1 29 UNP P01308 INS_HUMAN 25 53 DBREF 4AJX K 1 21 UNP P01308 INS_HUMAN 90 110 DBREF 4AJX L 1 29 UNP P01308 INS_HUMAN 25 53 SEQRES 1 A 21 GLY ILE VAL GLU GLN CYS CYS THR SER ILE CYS SER LEU SEQRES 2 A 21 TYR GLN LEU GLU ASN TYR CYS ASN SEQRES 1 B 29 PHE VAL ASN GLN HIS LEU CYS GLY SER HIS LEU VAL GLU SEQRES 2 B 29 ALA LEU TYR LEU VAL CYS GLY GLU ARG GLY PHE PHE TYR SEQRES 3 B 29 THR PRO LYS SEQRES 1 C 21 GLY ILE VAL GLU GLN CYS CYS THR SER ILE CYS SER LEU SEQRES 2 C 21 TYR GLN LEU GLU ASN TYR CYS ASN SEQRES 1 D 29 PHE VAL ASN GLN HIS LEU CYS GLY SER HIS LEU VAL GLU SEQRES 2 D 29 ALA LEU TYR LEU VAL CYS GLY GLU ARG GLY PHE PHE TYR SEQRES 3 D 29 THR PRO LYS SEQRES 1 E 21 GLY ILE VAL GLU GLN CYS CYS THR SER ILE CYS SER LEU SEQRES 2 E 21 TYR GLN LEU GLU ASN TYR CYS ASN SEQRES 1 F 29 PHE VAL ASN GLN HIS LEU CYS GLY SER HIS LEU VAL GLU SEQRES 2 F 29 ALA LEU TYR LEU VAL CYS GLY GLU ARG GLY PHE PHE TYR SEQRES 3 F 29 THR PRO LYS SEQRES 1 G 21 GLY ILE VAL GLU GLN CYS CYS THR SER ILE CYS SER LEU SEQRES 2 G 21 TYR GLN LEU GLU ASN TYR CYS ASN SEQRES 1 H 29 PHE VAL ASN GLN HIS LEU CYS GLY SER HIS LEU VAL GLU SEQRES 2 H 29 ALA LEU TYR LEU VAL CYS GLY GLU ARG GLY PHE PHE TYR SEQRES 3 H 29 THR PRO LYS SEQRES 1 I 21 GLY ILE VAL GLU GLN CYS CYS THR SER ILE CYS SER LEU SEQRES 2 I 21 TYR GLN LEU GLU ASN TYR CYS ASN SEQRES 1 J 29 PHE VAL ASN GLN HIS LEU CYS GLY SER HIS LEU VAL GLU SEQRES 2 J 29 ALA LEU TYR LEU VAL CYS GLY GLU ARG GLY PHE PHE TYR SEQRES 3 J 29 THR PRO LYS SEQRES 1 K 21 GLY ILE VAL GLU GLN CYS CYS THR SER ILE CYS SER LEU SEQRES 2 K 21 TYR GLN LEU GLU ASN TYR CYS ASN SEQRES 1 L 29 PHE VAL ASN GLN HIS LEU CYS GLY SER HIS LEU VAL GLU SEQRES 2 L 29 ALA LEU TYR LEU VAL CYS GLY GLU ARG GLY PHE PHE TYR SEQRES 3 L 29 THR PRO LYS HET 16E A1022 28 HET RCO B1030 8 HET NA B1031 1 HET RCO D1029 8 HET IMD D1030 10 HET RCO E1022 8 HET ZN F1029 1 HET RCO G1022 8 HET ZN H1030 1 HET 16E H1031 28 HET NA H1032 1 HET RCO J1029 8 HET IMD K1022 10 HET RCO L1030 8 HET IMD L1031 9 HETNAM 16E N-(16-CARBOXYHEXADECANOYL)-L-GLUTAMIC ACID HETNAM RCO RESORCINOL HETNAM NA SODIUM ION HETNAM IMD IMIDAZOLE HETNAM ZN ZINC ION HETSYN RCO 1,3-BENZENEDIOL; 1,3-DIHYDROXYBENZENE FORMUL 13 16E 2(C21 H37 N O7) FORMUL 14 RCO 6(C6 H6 O2) FORMUL 15 NA 2(NA 1+) FORMUL 17 IMD 3(C3 H5 N2 1+) FORMUL 19 ZN 2(ZN 2+) FORMUL 28 HOH *358(H2 O) HELIX 1 1 GLY A 1 CYS A 7 1 7 HELIX 2 2 SER A 12 GLU A 17 1 6 HELIX 3 3 PHE B 1 GLY B 20 1 20 HELIX 4 4 GLU B 21 GLY B 23 5 3 HELIX 5 5 GLY C 1 CYS C 7 1 7 HELIX 6 6 SER C 12 GLU C 17 1 6 HELIX 7 7 VAL D 2 CYS D 19 1 18 HELIX 8 8 GLY E 1 SER E 9 1 9 HELIX 9 9 SER E 12 ASN E 18 1 7 HELIX 10 10 PHE F 1 GLY F 20 1 20 HELIX 11 11 GLU F 21 GLY F 23 5 3 HELIX 12 12 GLY G 1 SER G 9 1 9 HELIX 13 13 SER G 12 ASN G 18 1 7 HELIX 14 14 PHE H 1 GLY H 20 1 20 HELIX 15 15 GLU H 21 GLY H 23 5 3 HELIX 16 16 GLY I 1 CYS I 7 1 7 HELIX 17 17 SER I 12 ASN I 18 1 7 HELIX 18 18 VAL J 2 GLY J 20 1 19 HELIX 19 19 GLU J 21 GLY J 23 5 3 HELIX 20 20 GLY K 1 SER K 9 1 9 HELIX 21 21 SER K 12 GLU K 17 1 6 HELIX 22 22 PHE L 1 GLY L 20 1 20 HELIX 23 23 GLU L 21 GLY L 23 5 3 SHEET 1 BA 2 PHE B 24 TYR B 26 0 SHEET 2 BA 2 PHE H 24 TYR H 26 -1 O PHE H 24 N TYR B 26 SHEET 1 DA 2 PHE D 24 TYR D 26 0 SHEET 2 DA 2 PHE L 24 TYR L 26 -1 O PHE L 24 N TYR D 26 SHEET 1 FA 2 PHE F 24 TYR F 26 0 SHEET 2 FA 2 PHE J 24 TYR J 26 -1 O PHE J 24 N TYR F 26 SSBOND 1 CYS A 6 CYS A 11 1555 1555 2.03 SSBOND 2 CYS A 7 CYS B 7 1555 1555 2.06 SSBOND 3 CYS A 20 CYS B 19 1555 1555 2.03 SSBOND 4 CYS C 6 CYS C 11 1555 1555 2.03 SSBOND 5 CYS C 7 CYS D 7 1555 1555 2.10 SSBOND 6 CYS C 20 CYS D 19 1555 1555 2.02 SSBOND 7 CYS E 6 CYS E 11 1555 1555 2.01 SSBOND 8 CYS E 7 CYS F 7 1555 1555 2.05 SSBOND 9 CYS E 20 CYS F 19 1555 1555 2.02 SSBOND 10 CYS G 6 CYS G 11 1555 1555 2.04 SSBOND 11 CYS G 7 CYS H 7 1555 1555 2.05 SSBOND 12 CYS G 20 CYS H 19 1555 1555 2.05 SSBOND 13 CYS I 6 CYS I 11 1555 1555 2.02 SSBOND 14 CYS I 7 CYS J 7 1555 1555 2.12 SSBOND 15 CYS I 20 CYS J 19 1555 1555 2.00 SSBOND 16 CYS K 6 CYS K 11 1555 1555 2.04 SSBOND 17 CYS K 7 CYS L 7 1555 1555 2.04 SSBOND 18 CYS K 20 CYS L 19 1555 1555 2.04 LINK C07 16E A1022 NZ LYS B 29 1555 1555 1.40 LINK NZ LYS H 29 C07 16E H1031 1555 1555 1.39 LINK O08 16E A1022 NA NA B1031 1555 1555 3.11 LINK O HOH A2004 NA NA B1031 1555 1555 2.85 LINK O HOH A2013 NA NA B1031 1555 1555 3.03 LINK OG CSER B 9 NA NA H1032 1555 1555 2.96 LINK NE2 HIS B 10 ZN ZN F1029 1555 1555 2.01 LINK NA NA B1031 O HOH B2037 1555 1555 2.92 LINK O HOH B2016 NA NA H1032 1555 1555 3.09 LINK NE2 HIS D 10 ZN ZN H1030 1555 1555 2.04 LINK NE2 HIS F 10 ZN ZN F1029 1555 1555 2.01 LINK ZN ZN F1029 NE2 HIS L 10 1555 1555 2.00 LINK ZN ZN F1029 N1 IMD L1031 1555 1555 1.82 LINK NE2 HIS H 10 ZN ZN H1030 1555 1555 2.04 LINK OE1AGLU H 13 NA NA H1032 1555 1555 2.41 LINK O GLU H 13 NA NA H1032 1555 1555 3.10 LINK ZN ZN H1030 O28 16E H1031 1555 1555 1.95 LINK ZN ZN H1030 NE2 HIS J 10 1555 1555 2.07 LINK NA NA H1032 OE2BGLU L 13 1555 1555 2.87 CISPEP 1 PRO H 28 LYS H 29 0 10.29 SITE 1 AC1 17 GLN A 15 ASN A 18 HOH A2006 HOH A2049 SITE 2 AC1 17 HOH A2050 HOH A2051 HOH A2052 HOH A2053 SITE 3 AC1 17 LYS B 29 NA B1031 TYR C 14 GLU C 17 SITE 4 AC1 17 VAL D 18 GLY D 20 GLU D 21 ARG D 22 SITE 5 AC1 17 TYR E 14 SITE 1 AC2 8 CYS A 6 ILE A 10 CYS A 11 HOH A2034 SITE 2 AC2 8 LEU B 11 ALA B 14 HOH B2018 HIS F 5 SITE 1 AC3 6 16E A1022 HOH A2004 HOH A2013 LYS B 29 SITE 2 AC3 6 HOH B2037 ARG D 22 SITE 1 AC4 9 CYS C 6 SER C 9 ILE C 10 CYS C 11 SITE 2 AC4 9 HOH C2020 LEU D 11 ALA D 14 HOH D2023 SITE 3 AC4 9 HIS J 5 SITE 1 AC5 4 GLU D 13 GLU H 13 GLU J 13 GLU L 13 SITE 1 AC6 8 LEU D 17 CYS E 6 SER E 9 ILE E 10 SITE 2 AC6 8 CYS E 11 HOH E2012 LEU F 11 HIS L 5 SITE 1 AC7 4 HIS B 10 HIS F 10 HIS L 10 IMD L1031 SITE 1 AC8 7 HIS D 5 CYS G 6 ILE G 10 CYS G 11 SITE 2 AC8 7 HOH G2025 ALA H 14 LEU L 17 SITE 1 AC9 4 HIS D 10 HIS H 10 16E H1031 HIS J 10 SITE 1 BC1 13 ASN D 3 LEU D 6 HIS D 10 HOH D2007 SITE 2 BC1 13 VAL G 3 GLU G 4 CYS G 7 ASN H 3 SITE 3 BC1 13 GLN H 4 HIS H 10 ZN H1030 LEU J 6 SITE 4 BC1 13 HIS J 10 SITE 1 BC2 6 SER B 9 HOH B2016 GLU H 13 TYR H 16 SITE 2 BC2 6 LEU H 17 GLU L 13 SITE 1 BC3 7 HIS H 5 CYS I 6 ILE I 10 CYS I 11 SITE 2 BC3 7 HOH I2012 LEU J 11 ALA J 14 SITE 1 BC4 4 GLN K 5 CYS K 11 TYR K 19 HOH K2022 SITE 1 BC5 8 HIS B 5 CYS K 6 ILE K 10 CYS K 11 SITE 2 BC5 8 HOH K2018 LEU L 11 ALA L 14 HOH L2003 SITE 1 BC6 7 HIS B 10 LEU F 6 HIS F 10 ZN F1029 SITE 2 BC6 7 HOH F2003 LEU L 6 HIS L 10 CRYST1 47.310 62.490 57.270 90.00 111.80 90.00 P 1 21 1 12 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.021137 0.000000 0.008454 0.00000 SCALE2 0.000000 0.016003 0.000000 0.00000 SCALE3 0.000000 0.000000 0.018806 0.00000